Free Trial

Protara Therapeutics (TARA) Short Interest Ratio & Short Volume

$2.80
+0.04 (+1.45%)
(As of 05/24/2024 04:00 PM ET)

Protara Therapeutics Short Interest Data

Current Short Interest
1,030,000 shares
Previous Short Interest
398,300 shares
Change Vs. Previous Month
+158.60%
Dollar Volume Sold Short
$3.07 million
Short Interest Ratio
3.5 Days to Cover
Last Record Date
April 30, 2024
Outstanding Shares
20,590,000 shares
Percentage of Shares Shorted
5.00%
Today's Trading Volume
222,100 shares
Average Trading Volume
271,430 shares
Today's Volume Vs. Average
82%
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook
Short Selling Protara Therapeutics ?

Sign up to receive the latest short interest report for Protara Therapeutics and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

TARA Short Interest Over Time

TARA Days to Cover Over Time

TARA Percentage of Float Shorted Over Time

Protara Therapeutics Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
4/30/20241,030,000 shares $3.07 million +158.6%N/A3.5 $2.98
4/15/2024398,300 shares $1.13 million +510.9%4.4%1.6 $2.84
3/31/202465,200 shares $261,452.00 +6.2%0.7%0.3 $4.01
3/15/202461,400 shares $225,952.00 -22.3%0.7%0.8 $3.68
2/29/202479,000 shares $360,240.00 +33.9%0.9%1.1 $4.56
2/15/202459,000 shares $208,270.00 -33.0%0.7%0.8 $3.53
1/31/202488,100 shares $224,655.00 +19.2%1.1%1.5 $2.55
1/15/202473,900 shares $170,709.00 +1.5%0.9%1.3 $2.31
12/31/202372,800 shares $136,507.28 +46.8%0.9%1.3 $1.88
12/15/202349,600 shares $88,288.00 -16.2%0.6%1.1 $1.78
11/30/202359,200 shares $85,840.00 +22.3%0.7%1.6 $1.45
11/15/202348,400 shares $58,080.00 +1.7%0.6%1.6 $1.20
10/31/202347,600 shares $59,271.52 -3.3%0.6%1.9 $1.25
10/15/202349,200 shares $81,180.00 -4.3%0.6%2.5 $1.65
9/30/202351,400 shares $85,838.00 +5.5%0.6%2.2 $1.67
9/15/202348,700 shares $90,095.00 -7.4%0.6%1.8 $1.85
8/31/202352,600 shares $114,668.00 +14.4%0.6%1.8 $2.18
8/15/202346,000 shares $109,020.00 -40.8%0.6%1.4 $2.37
7/31/202377,700 shares $201,243.00 -28.5%0.9%2.3 $2.59
7/15/2023108,600 shares $298,650.00 +10.0%1.3%2.9 $2.75
6/30/202398,700 shares $235,893.00 -9.0%1.2%2.7 $2.39
6/15/2023108,400 shares $308,940.00 +11.0%1.3%3.2 $2.85
5/31/202397,700 shares $272,583.00 +0.2%1.2%2.7 $2.79
5/15/202397,500 shares $328,575.00 -4.6%1.2%2.6 $3.37
4/30/2023102,200 shares $322,952.00 +34.1%1.2%3.2 $3.16
4/15/202376,200 shares $221,742.00 -0.4%0.9%2.4 $2.91
3/31/202376,500 shares $239,445.00 -0.4%0.9%3.2 $3.13
3/15/202376,800 shares $235,776.00 -0.9%0.9%3.2 $3.07
2/28/202377,500 shares $273,575.00 -5.8%0.9%4.2 $3.53
2/15/202382,300 shares $264,183.00 -2.4%0.9%4.5 $3.21
1/31/202384,300 shares $275,239.50 -0.6%1.0%3.5 $3.27
1/15/202384,800 shares $284,928.00 -1.5%1.0%3.2 $3.36
12/30/202286,100 shares $230,748.00 +8.4%1.0%3 $2.68
12/15/202279,400 shares $243,758.00 -30.8%0.9%2.5 $3.07
11/30/2022114,700 shares $404,891.00 +22.7%1.3%3 $3.53
11/15/202293,500 shares $276,760.00 +7.5%1.0%2.2 $2.96
10/31/202287,000 shares $267,090.00 +2.7%1.0%2 $3.07
10/15/202284,700 shares $281,204.00 -16.6%1.0%2.1 $3.32
9/30/2022101,600 shares $300,736.00 -9.5%1.2%2.8 $2.96
9/15/2022112,200 shares $433,092.00 +14.5%1.3%2.6 $3.86
WARNING about the death of the U.S. dollar… (Ad)

Where do you turn during times of economic uncertainty? Many elites trust storing their wealth in gold (which has historically boomed when the dollar’s value has plummeted!)

Get Colonial Metals' new Precious Metals Investment Guide.
8/31/202298,000 shares $338,100.00 +9.0%1.2%2.3 $3.45
8/15/202289,900 shares $311,953.00 -1.0%1.1%2.4 $3.47
7/31/202290,800 shares $271,492.00 -32.7%1.1%2.4 $2.99
7/15/2022135,000 shares $422,550.00 +32.1%1.6%3.6 $3.13
6/30/2022102,200 shares $299,446.00 -32.4%1.2%2.7 $2.93
6/15/2022151,200 shares $471,744.00 -5.0%1.8%4.7 $3.12
5/31/2022159,200 shares $531,728.00 +5.5%1.9%5.6 $3.34
5/15/2022150,900 shares $436,101.00 +1.6%1.8%4.9 $2.89
4/30/2022148,500 shares $543,510.00 -6.8%1.8%4.9 $3.66
4/15/2022159,400 shares $730,052.00 -15.5%1.9%4.8 $4.58
3/31/2022188,700 shares $964,257.00 -8.0%2.2%5 $5.11
3/15/2022205,100 shares $916,797.00 -30.4%2.4%3.9 $4.47
2/28/2022294,500 shares $1.36 million +17.9%3.5%5.1 $4.63
2/15/2022249,900 shares $1.31 million -10.3%3.0%4 $5.25
1/31/2022278,500 shares $1.45 million -8.3%3.2%3.7 $5.21
1/15/2022303,700 shares $1.93 million -19.8%3.4%3.5 $6.37
12/31/2021378,600 shares $2.56 million -3.1%4.2%1.2 $6.75
12/15/2021390,700 shares $2.56 million +32.3%4.3%1.3 $6.56
11/30/2021295,300 shares $2.03 million -7.4%3.2%0.9 $6.89
11/15/2021318,800 shares $2.28 million -11.4%3.5%1 $7.15
10/29/2021359,600 shares $2.49 million -20.7%4.0%1.1 $6.92
10/15/2021453,400 shares $3.10 million +249.9%5.0%1.4 $6.84
9/30/2021129,600 shares $896,832.00 -36.0%1.4%1.2 $6.92
9/15/2021202,600 shares $1.44 million -1.9%2.2%1.8 $7.10
8/31/2021206,600 shares $1.73 million +9.3%2.3%2.3 $8.39
8/13/2021189,000 shares $1.33 million -2.3%2.1%1.9 $7.03
7/30/2021193,400 shares $1.53 million +1.9%2.1%2.1 $7.93
7/15/2021189,800 shares $1.61 million +27.9%2.0%1.4 $8.48
6/30/2021148,400 shares $1.45 million -52.2%1.6%1 $9.74
6/15/2021310,700 shares $3.26 million +2.4%3.3%2.3 $10.49
5/28/2021303,300 shares $2.88 million -1.1%3.2%2.2 $9.48
5/14/2021306,800 shares $2.66 million -10.7%3.2%2.4 $8.68
4/30/2021343,400 shares $3.91 million +20.2%3.5%2.6 $11.39
4/15/2021285,700 shares $4.85 million -1.1%2.9%2.4 $16.99
3/31/2021288,900 shares $4.07 million +38.8%3.0%3.1 $14.10
3/15/2021208,200 shares $3.71 million +34.2%2.1%2.1 $17.82
2/26/2021155,100 shares $2.73 million +14.1%1.6%1.6 $17.61
2/12/2021135,900 shares $2.77 million +0.3%1.4%1.5 $20.37
1/29/2021135,500 shares $2.56 million +25.1%1.4%1.4 $18.88
1/15/2021108,300 shares $2.18 million -2.0%1.1%1.2 $20.14
12/31/2020110,500 shares $2.67 million +83.3%1.2%1.2 $24.15
12/15/202060,300 shares $1.34 million +45.0%0.6%0.5 $22.17
11/30/202041,600 shares $965,120.00 -19.2%0.4%0.4 $23.20
11/15/202051,500 shares $1.11 million +12.5%0.5%0.5 $21.48
10/30/202045,800 shares $854,628.00 +23.8%0.5%0.5 $18.66
10/15/202037,000 shares $696,710.00 +6.6%0.4%0.5 $18.83
9/30/202034,700 shares $584,001.00 -28.8%0.4%0.6 $16.83
9/15/202048,700 shares $946,728.00 -6.4%1.1%1.4 $19.44
8/31/202052,000 shares $1.11 million -7.6%1.2%1.8 $21.40
8/14/202056,300 shares $1.35 million -8.8%1.3%1.9 $24.00
Get Ahead in 2024: Key Stocks to Watch! (Ad)

Welcome to a promising year ahead! We're excited to share our carefully curated guide, "Top 9 Stocks to Watch," designed to enhance your investment strategy in 2024. Click below to opt-in and receive up to two additional free bonus subscriptions. Unsubscribe at any time.

Access Your Exclusive Report Now
7/31/202061,700 shares $1.54 million +23.7%1.5%2.1 $24.94
7/15/202049,900 shares $1.33 million +7.8%1.2%2 $26.67
6/30/202046,300 shares $1.43 million +223.8%1.1%1.9 $30.80
6/15/202014,300 shares $434,148.00 +210.9%0.4%0.8 $30.36
5/29/20204,600 shares $223,054.00 +12.2%0.1%0.3 $48.49
5/15/20204,100 shares $98,605.00 +86.4%0.1%0.4 $24.05
4/30/20202,200 shares $53,900.00 -42.1%0.1%0.2 $24.50
4/15/20203,800 shares $91,200.00 -33.3%0.1%0.3 $24.00
3/31/20205,700 shares $136,629.00 +42.5%0.1%0.4 $23.97
3/13/20204,000 shares $89,240.00 +400.0%0.8%0.4 $22.31
2/28/2020800 shares $16,816.00 -89.2%0.2%0.1 $21.02
2/14/20207,400 shares $179,080.00 +1.4%1.4%0.5 $24.20
1/31/20207,300 shares $202,210.00 +10.6%3.3%0.6 $27.70
1/15/20206,600 shares $246,180.00 -88.7%N/A0.8 $37.30
12/31/201958,500 shares $1.96 million No ChangeN/A7.8 $33.50

TARA Short Interest - Frequently Asked Questions

What is Protara Therapeutics' current short interest?

Short interest is the volume of Protara Therapeutics shares that have been sold short but have not yet been covered or closed out. As of April 30th, investors have sold 1,030,000 shares of TARA short. Learn More on Protara Therapeutics' current short interest.

What is a good short interest ratio for Protara Therapeutics?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. TARA shares currently have a short interest ratio of 4.0. Learn More on Protara Therapeutics's short interest ratio.

Is Protara Therapeutics' short interest increasing or decreasing?

Protara Therapeutics saw a increase in short interest during the month of April. As of April 30th, there was short interest totaling 1,030,000 shares, an increase of 158.6% from the previous total of 398,300 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does Protara Therapeutics' short interest compare to its competitors?

Here is how the short interest of companies in the sector of "medical" compare to Protara Therapeutics: Curis, Inc. (1.14%), Champions Oncology, Inc. (0.95%), Turnstone Biologics Corp. (5.22%), Genenta Science S.p.A. (0.03%), Ikena Oncology, Inc. (5.99%), Aligos Therapeutics, Inc. (1.07%), Dyadic International, Inc. (0.96%), Cidara Therapeutics, Inc. (2.04%), Instil Bio, Inc. (0.19%), IN8bio, Inc. (0.60%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks.

What does it mean to sell short Protara Therapeutics stock?

Short selling TARA is an investing strategy that aims to generate trading profit from Protara Therapeutics as its price is falling. TARA shares are trading up $0.04 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Protara Therapeutics?

A short squeeze for Protara Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of TARA, which in turn drives the price of the stock up even further.

How often is Protara Therapeutics' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including TARA, twice per month. The most recent reporting period available is April, 30 2024.



More Short Interest Resources from MarketBeat

This page (NASDAQ:TARA) was last updated on 5/27/2024 by MarketBeat.com Staff

From Our Partners